SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-311686
Filing Date
2019-12-11
Accepted
2019-12-11 17:27:58
Documents
1
Group Members
ARIX BIOSCIENCE HOLDINGS LTDMARK CHIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d644278dsc13da.htm SC 13D/A 61353
  Complete submission text file 0001193125-19-311686.txt   62928
Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90935 | Film No.: 191280472
SIC: 2836 Biological Products, (No Diagnostic Substances)